Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Nitrendipine

39562-70-4C18H20N2O6360.366 g/mol

A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number39562-70-4ChEBI ↗
Molecular formulaC18H20N2O6ChEBI ↗
Molar mass360.366 g/molChEBI ↗
Monoisotopic mass360.13214 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:7582ChEBI ↗

Cross-source molecular data

PubChem
Molar mass360.4 g/molPubChem ↗
Exact mass360.13213636 DaPubChem ↗
Computed XLogP2.9PubChem ↗
Topological polar surface area (Ų)110PubChem ↗
H-bond donors1PubChem ↗
H-bond acceptors7PubChem ↗
Rotatable bonds6PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
nitrendipine
ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
PVHUJELLJLJGLN-UHFFFAOYSA-N
CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1
InChI=1S/C18H20N2O6/c1-5-26-18(22)15-11(3)19-10(2)14(17(21)25-4)16(15)12-7-6-8-13(9-12)20(23)24/h6-9,16,19H,5H2,1-4H3

Names & synonyms

BayotensinBaypressBylotensinDeitenethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylateNidrelnitrendipinonitrendipinum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

geroprotectorcardiovascular drugvasodilator agentantihypertensive agentcalcium channel blocker

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00277496 mol

Uses 360.366 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 18 atoms
59.99%
O
Oxygen · 6 atoms
26.64%
N
Nitrogen · 2 atoms
7.77%
H
Hydrogen · 20 atoms
5.59%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Nitrendipine and metabolic balance. ↗Journal of cardiovascular pharmacology · 1991 · PMID 1725797
Metabolic effects of nitrendipine. ↗Clinical therapeutics · 1991 Nov-Dec · PMID 1790544
CN101416954 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
DE2117571 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US3799934 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:7582

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 4507 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.